Video

Dr Hatz Vlog: Insights from a clinician CEO – Episode 8

13 October 2025

Video Digital, Data & AI Health and care professionalsInnovator hub

How can AI detect lung cancers up to 12 months earlier than traditional methods?

Health Innovation Kent Surrey Sussex CEO, Dr Hatim Abdulhussein, talks to David Howell, CEO of Quantum Analytica, about how AI can aid risk stratification, specifically with early diagnosis.

Read more about our work with innovators in the cancer space here.

If you’re an innovator and want to find out more about how we can support you, visit our Innovator hub and complete our innovator engagement form.

Related news

Dr Hatz Vlog: Insights from a clinician CEO – Episode 9

Professor Hatim Abdulhussein talks to Rachael Grimaldi, Co-Founder and CEO of CardMedic, a frontline healthcare language app. In this discussion, Rachael shares the latest on how the use of AI is enabling their technologies to scale and reflects on the support she received from the Health Innovation KSS Enterprise and Industry team.

Video

13 Jan 2026

Dr Hatz Vlog: Insights from a clinician CEO – Episode 10

Health Innovation KSS CEO, Prof. Hatim Abudulhussein (Dr Hatz), and Sarah Barker from our Enterprise and Industry team chat with precision radiotherapy specialists Elekta. Learn how its technology can result in better patient outcomes and how we helped it develop its offer to the NHS.

Video

14 Jan 2026

Dr Hatz Vlog: Insights from a clinician CEO – Episode 7

The Surrey AI Roundtable Series, co-led by NHS Surrey Heartlands and Health Innovation KSS, brought together over 50 stakeholders from healthcare, academia, and industry to co-develop a strategic blueprint for responsible AI adoption.

Video

18 Jul 2025

Dr Hatz Vlog: Insights from a clinician CEO – Episode 7

Video

18 Jul 2025

See all